Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

.15+ by end of year seems very possible assuming first orders for LymPro are announced or the O.D.D. for MANF for Retinitis Pigmentosa is granted.

If both events occur .20+ is possible depending on follow-up related events.

Despite what many of the "whales" want to believe Gerald needs some substantive news to restore his credibility with the retail market. If this isn't true then why is the share price at .084?

Twitter: @AmarantusBio .... 10,200 followers.


p.s. I'm expecting the up-listing to occur in 2Q2015. No sooner.